BioSpace News Archive

Increasing levels of a simplified version of “good” cholesterol reversed disease in the blood vessels of mice with diabetes, a new study finds.

The Bia-Echo Foundation and the Buck Institute for Research on Aging today announced the formation of the Global Consortium for Female Reproductive Longevity and Equality.

Today the Accreditation Council for Graduate Medical Education (ACGME) released its 2018-2019 Data Resource Book, the most comprehensive and reliable resource of its kind, including data on the size, scope, and distribution of graduate medical education (GME) in the U.S.

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the completion of patient enrollment in the Eversense PROMISE 180-day sensor Clinical Study.

HealthWarehouse.com, Inc. (OTC Pink:HEWA), a Verified Internet Pharmacy Practice Site (VIPPS) accredited online pharmacy licensed and/or authorized to sell in all 50 states serving consumers who pay out of pocket for their prescriptions, today announced that its shareholders have elected nominees to new one-year terms on its Board of Directors and ratified the appointment of its auditing firm for the 2019 fiscal year.

McKesson Corporation (NYSE:MCK) announced today that its second quarter fiscal 2020 financial results will be released before market open on Wednesday, October 30, 2019.

IVERIC bio, Inc. announced that Glenn P. Sblendorio, Chief Executive Officer and President of IVERIC bio, will present an overview of the Company at the Chardan Capital Markets 3rd Annual Genetic Medicines Conference in New York on Monday, October 7, 2019 at 8:00 a.m. Eastern Time.

Dr. Broom most recently served as CEO at Nabriva Therapeutics plc, where he continues as a board member.

Involved in organized dentistry throughout his career, Dr. McDonnell has served within numerous leadership positions.

IsoPlexis’ functional single cell proteomics methods published as an emerging standard in the discovery and development of key biomarkers in cancer immunotherapies.